vs
Side-by-side financial comparison of ICU MEDICAL INC (ICUI) and VILLAGE SUPER MARKET INC (VLGEA). Click either name above to swap in a different company.
VILLAGE SUPER MARKET INC is the larger business by last-quarter revenue ($582.6M vs $540.7M, roughly 1.1× ICU MEDICAL INC). VILLAGE SUPER MARKET INC runs the higher net margin — 2.1% vs -2.9%, a 5.0% gap on every dollar of revenue. On growth, VILLAGE SUPER MARKET INC posted the faster year-over-year revenue change (4.5% vs -14.1%). ICU MEDICAL INC produced more free cash flow last quarter ($36.0M vs $10.7M). Over the past eight quarters, VILLAGE SUPER MARKET INC's revenue compounded faster (0.6% CAGR vs -2.3%).
ICU Medical, Inc. is a medical technology company based in San Clemente, California. ICU Medical products are designed to prevent bloodstream infections and protect healthcare workers from exposure to infectious diseases or hazardous drugs. ICU Medical product line includes intravenous therapy (IV) products, pumps, needle-free vascular access devices, custom infusion sets, closed system hazardous drug handling devices and systems, sensor catheters, needle-free closed blood sampling systems, a...
A supermarket is a self-service shop offering a wide variety of food, beverages and household products, organized into sections under one roof. The supermarket retail format first appeared around 1930 in the United States as the culmination of almost two decades of retail innovations to the grocery store, and began to spread to other countries after extensive worldwide publicity in 1956. In everyday American English usage, "grocery store" is often used interchangeably with "supermarket", whil...
ICUI vs VLGEA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $540.7M | $582.6M |
| Net Profit | $-15.7M | $12.0M |
| Gross Margin | 37.5% | 28.3% |
| Operating Margin | 1.0% | 2.6% |
| Net Margin | -2.9% | 2.1% |
| Revenue YoY | -14.1% | 4.5% |
| Net Profit YoY | 34.0% | -6.3% |
| EPS (diluted) | $-0.63 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $540.7M | $582.6M | ||
| Q3 25 | $537.0M | $599.7M | ||
| Q2 25 | $548.9M | $563.7M | ||
| Q1 25 | $604.7M | $599.7M | ||
| Q4 24 | $629.8M | $557.7M | ||
| Q3 24 | $589.1M | $578.2M | ||
| Q2 24 | $596.5M | $546.4M | ||
| Q1 24 | $566.7M | $575.6M |
| Q4 25 | $-15.7M | $12.0M | ||
| Q3 25 | $-3.4M | $15.5M | ||
| Q2 25 | $35.3M | $11.2M | ||
| Q1 25 | $-15.5M | $16.9M | ||
| Q4 24 | $-23.8M | $12.8M | ||
| Q3 24 | $-33.0M | $15.4M | ||
| Q2 24 | $-21.4M | $9.0M | ||
| Q1 24 | $-39.5M | $14.5M |
| Q4 25 | 37.5% | 28.3% | ||
| Q3 25 | 37.4% | 28.2% | ||
| Q2 25 | 37.9% | 28.8% | ||
| Q1 25 | 34.7% | 28.4% | ||
| Q4 24 | 36.1% | 29.0% | ||
| Q3 24 | 34.8% | 29.3% | ||
| Q2 24 | 34.8% | 28.5% | ||
| Q1 24 | 32.7% | 28.4% |
| Q4 25 | 1.0% | 2.6% | ||
| Q3 25 | 2.6% | 3.4% | ||
| Q2 25 | 1.9% | 2.4% | ||
| Q1 25 | 2.1% | 3.7% | ||
| Q4 24 | 6.0% | 2.9% | ||
| Q3 24 | 1.4% | 3.3% | ||
| Q2 24 | 1.3% | 1.9% | ||
| Q1 24 | -1.9% | 3.2% |
| Q4 25 | -2.9% | 2.1% | ||
| Q3 25 | -0.6% | 2.6% | ||
| Q2 25 | 6.4% | 2.0% | ||
| Q1 25 | -2.6% | 2.8% | ||
| Q4 24 | -3.8% | 2.3% | ||
| Q3 24 | -5.6% | 2.7% | ||
| Q2 24 | -3.6% | 1.6% | ||
| Q1 24 | -7.0% | 2.5% |
| Q4 25 | $-0.63 | — | ||
| Q3 25 | $-0.14 | — | ||
| Q2 25 | $1.43 | — | ||
| Q1 25 | $-0.63 | — | ||
| Q4 24 | $-0.97 | — | ||
| Q3 24 | $-1.35 | — | ||
| Q2 24 | $-0.88 | — | ||
| Q1 24 | $-1.63 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $117.7M |
| Total DebtLower is stronger | — | $55.7M |
| Stockholders' EquityBook value | $2.1B | $501.1M |
| Total Assets | $4.1B | $1.0B |
| Debt / EquityLower = less leverage | — | 0.11× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $117.7M | ||
| Q3 25 | — | $110.7M | ||
| Q2 25 | — | $115.4M | ||
| Q1 25 | — | $133.9M | ||
| Q4 24 | $308.6M | $117.2M | ||
| Q3 24 | $312.5M | $117.3M | ||
| Q2 24 | $302.6M | $113.9M | ||
| Q1 24 | $251.4M | $133.3M |
| Q4 25 | — | $55.7M | ||
| Q3 25 | — | $58.0M | ||
| Q2 25 | — | $60.3M | ||
| Q1 25 | — | $62.7M | ||
| Q4 24 | — | $69.9M | ||
| Q3 24 | — | $72.2M | ||
| Q2 24 | — | $74.6M | ||
| Q1 24 | — | $77.0M |
| Q4 25 | $2.1B | $501.1M | ||
| Q3 25 | $2.1B | $492.0M | ||
| Q2 25 | $2.1B | $479.7M | ||
| Q1 25 | $2.0B | $472.0M | ||
| Q4 24 | $2.0B | $457.5M | ||
| Q3 24 | $2.0B | $447.6M | ||
| Q2 24 | $2.0B | $436.2M | ||
| Q1 24 | $2.1B | $429.1M |
| Q4 25 | $4.1B | $1.0B | ||
| Q3 25 | $4.1B | $1.0B | ||
| Q2 25 | $4.1B | $995.6M | ||
| Q1 25 | $4.2B | $1.0B | ||
| Q4 24 | $4.2B | $990.3M | ||
| Q3 24 | $4.3B | $981.7M | ||
| Q2 24 | $4.3B | $970.2M | ||
| Q1 24 | $4.3B | $970.4M |
| Q4 25 | — | 0.11× | ||
| Q3 25 | — | 0.12× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.15× | ||
| Q3 24 | — | 0.16× | ||
| Q2 24 | — | 0.17× | ||
| Q1 24 | — | 0.18× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $60.6M | $19.7M |
| Free Cash FlowOCF − Capex | $36.0M | $10.7M |
| FCF MarginFCF / Revenue | 6.6% | 1.8% |
| Capex IntensityCapex / Revenue | 4.6% | 1.5% |
| Cash ConversionOCF / Net Profit | — | 1.64× |
| TTM Free Cash FlowTrailing 4 quarters | $91.8M | $36.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $60.6M | $19.7M | ||
| Q3 25 | $56.7M | $21.7M | ||
| Q2 25 | $11.2M | $10.6M | ||
| Q1 25 | $51.3M | $40.8M | ||
| Q4 24 | $40.2M | $20.2M | ||
| Q3 24 | $36.1M | $22.8M | ||
| Q2 24 | $82.0M | $9.4M | ||
| Q1 24 | $45.8M | $30.3M |
| Q4 25 | $36.0M | $10.7M | ||
| Q3 25 | $27.6M | $11.6M | ||
| Q2 25 | $-8.5M | $-10.6M | ||
| Q1 25 | $36.7M | $24.9M | ||
| Q4 24 | $16.1M | $8.5M | ||
| Q3 24 | $16.2M | $13.8M | ||
| Q2 24 | $62.5M | $-10.0M | ||
| Q1 24 | $29.9M | $9.3M |
| Q4 25 | 6.6% | 1.8% | ||
| Q3 25 | 5.1% | 1.9% | ||
| Q2 25 | -1.5% | -1.9% | ||
| Q1 25 | 6.1% | 4.2% | ||
| Q4 24 | 2.6% | 1.5% | ||
| Q3 24 | 2.7% | 2.4% | ||
| Q2 24 | 10.5% | -1.8% | ||
| Q1 24 | 5.3% | 1.6% |
| Q4 25 | 4.6% | 1.5% | ||
| Q3 25 | 5.4% | 1.7% | ||
| Q2 25 | 3.6% | 3.8% | ||
| Q1 25 | 2.4% | 2.6% | ||
| Q4 24 | 3.8% | 2.1% | ||
| Q3 24 | 3.4% | 1.6% | ||
| Q2 24 | 3.3% | 3.5% | ||
| Q1 24 | 2.8% | 3.7% |
| Q4 25 | — | 1.64× | ||
| Q3 25 | — | 1.40× | ||
| Q2 25 | 0.32× | 0.95× | ||
| Q1 25 | — | 2.41× | ||
| Q4 24 | — | 1.58× | ||
| Q3 24 | — | 1.48× | ||
| Q2 24 | — | 1.04× | ||
| Q1 24 | — | 2.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
VLGEA
| Center Store | $342.7M | 59% |
| Fresh | $211.0M | 36% |
| Pharmacy | $26.3M | 5% |
| Other Product | $2.6M | 0% |
